Microbiota Restoration in Recurrent C. difficile and COVID-19 : Sponsored by ACHL Academy for Continued Healthcare Learning Activity

Microbiota Restoration in Recurrent C. difficile (C. diff. ) and COVID-19

Intended Audience

This activity is intended for gastroenterologists, infectious disease specialists, and other clinicians who care for patients at risk of serious infection.

Activity Purpose: While the incidence of multiply recurrent C. difficile continues to rise, FMT has emerged as a means to break the cycle. Amid the current COVID-19 pandemic, clinicians should be aware of the additional safety concerns that have arisen. Expert faculty will discuss approaches to FMT including sourcing and screening of donor stool, which requires heightened safety measures during the COVID-19 pandemic. This activity is the first in a series of two educational activities that address the latest data on treating patients who experience rCDI.

Please click on the following link to be redirected to the activity

(Expires on September 6, 2020)

https://www.achlcme.org/COVID-19-MicrobiotaRestoration

C Diff Foundation

Educating and Advocating for the Prevention, Treatments, Clinical Trials, Environmental Safety of Clostridioides difficile (C. diff. CDI C. difficile) Infections Worldwide

Microbiota Restoration in Recurrent C. difficile and COVID-19 : Sponsored by ACHL Academy for Continued Healthcare Learning Activity

Share this: